Navigation Links
Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008
Date:1/28/2009

our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and, future business decisions made by us and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item IA- Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A - Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file thereafter. We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements. This cautionary statement is applicable to all forward-looking statements contained in this document.

Use of non-GAAP Financial Information

A reconciliation of the Company's non-GAAP financial measures to the corresponding GAAP measures, and an explanation of the Company's use of these non-GAAP measures, is included in the exhibits attached to this press release.

                                              CONTACT:
                                      
'/>"/>
SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related medicine news :

1. Boston Scientific and Medtronic Reach Agreement on Patent Disputes
2. Its Cold Outside! Warm Up in Select Downtown Boston Heated Bus Shelters Courtesy of TYLENOL(r) Warming Liquids
3. Boston Scientific Awarded CRM Contract by Department of Veterans Affairs
4. BioMed Realty Trusts Center for Life Science Boston Now 91% Leased
5. Boston Scientific Announces Court Decision
6. Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and 2008 Financial Results
7. Boston Scientific to Participate in JP Morgan Health Care Conference
8. Boston Hyundai Dealer Teams up With the Red Cross to Save Lives
9. BMC, Boston University School of Medicine dermatologist named one of Americas Top Doctors
10. BMC, Boston University School of Medicine cardiologist named 1 of Americas Top Doctors
11. Boston University Medical Center gynecologist named one of Americas top doctors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... June 02, 2015 Colleen’s Dream Foundation ... granted $70,000 to the UNMC to support ovarian cancer research ... Cundiff, a member of the Colleen’s Dream Foundation Board of ... the biggest to date for Colleen’s Dream Foundation and they ... Omaha. , “Dr. Wang is a rising star in the ...
(Date:6/2/2015)... June 02, 2015 While the movie ... of comic books, comic books themselves are stepping into ... Uniting Nations plans to produce educational comics in multiple ... Goals for Sustainable Development - an international effort to ... hunger, health, education, sustainable energy, inequality, climate change and ...
(Date:6/2/2015)... 02, 2015 Pacifica Graduate Institute ... up by current and former students to honor the ... member from 2002 until his death in 2013. His ... depth of feeling, as well as his passion for ... as an analyst, teacher, and writer were felt in ...
(Date:6/1/2015)... (PRWEB) June 02, 2015 The ... Lynn Lester as a 2015-2016 inductee into its ... with this prestigious distinction for leadership in business. NAPW ... women, boasting more than 700,000 members and over 200 ... Lester with this prestigious award,” said NAPW President Star ...
(Date:6/1/2015)... (PRWEB) June 02, 2015 The ... Linda Cade as a 2015-2016 inductee into its ... with this prestigious distinction for leadership in business. NAPW ... women, boasting more than 700,000 members and over 200 ... with this important honor,” said NAPW President Star Jones. ...
Breaking Medicine News(10 mins):Health News:Colleen’s Dream Foundation Grants $70,000 to the University of Nebraska Medical Center (UNMC) to Support Ovarian Cancer Research 2Health News:Colleen’s Dream Foundation Grants $70,000 to the University of Nebraska Medical Center (UNMC) to Support Ovarian Cancer Research 3Health News:Can Comics Help the United Nations Save the World? 2Health News:Can Comics Help the United Nations Save the World? 3Health News:Pacifica Graduate Institute - Mythological Studies Students Establish Memorial Scholarship to Honor Dr. V. Walter Odajnyk 2Health News:Pacifica Graduate Institute - Mythological Studies Students Establish Memorial Scholarship to Honor Dr. V. Walter Odajnyk 3Health News:National Association of Professional Women Inducts Lynn Lester, Director of Clinical Operations/CEO, Recovery Treatment Center, Into its VIP Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Linda Cade, Senior Product Manager at Sage, Into its VIP Professional Woman of the Year Circle 2
... RIDGE, N.J., Oct. 19 VioQuest,Pharmaceuticals (OTC ... focused on acquiring, developing and,commercializing targeted cancer ... data in poster presentations pertaining to VQD-002 ... and Cancer Therapeutics",International Conference sponsored by the ...
... CSV ) today announced plans to release 2007 third quarter ... conjunction with the,release, Carriage Services has scheduled a conference call, ... 2, 2007 at 10:00,a.m. eastern time. What: ... When: Friday, November 2, 2007 ...
... Amedisys, Inc.,(Nasdaq: AMED or the "Company"), one of ... intends to release its financial,results for the quarter ended ... Company will also host a conference call with the,investment ... To participate in the conference call, please dial 800-683-1525,(Domestic) ...
... US Oncology Holdings, Inc. and its,operating subsidiary, US ... on Thursday, November 8, 2007. A conference ... at 10:00,a.m., EST, for the company,s bondholders following ... representatives of US Oncology,s management,team will discuss the ...
... poor, uninsured,women in Pennsylvania will no longer have ... Prevention Project has ended. "Poor,women are going to ... funding for this critical program," declared Dorothy Mann, ... "We had a,Democratic supporter who worked with a ...
... Association of,Dental Plans (NADP) calls on Congress and the ... Program (CHIP).,Specifically, NADP urges prompt action to enact the ... bill., In letters to congressional health policy leaders, ... Dental services should be a mandatory CHIP benefit. ...
Cached Medicine News:Health News:VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting 2Health News:VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting 3Health News:VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting 4Health News:VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting 5Health News:Carriage Services Announces Third Quarter Earnings Release and Conference Call Schedule 2Health News:Amedisys to Host Conference Call to Discuss Third Quarter Financial Performance and Operating Results 2Health News:Pa. Funding for Cervical Cancer Prevention Services Ends 2Health News:NADP Calls on Congress and the White House to Work Together to Cover Children's Dental Health 2
(Date:6/1/2015)... PARK, Calif. , June 1, 2015 ... device company that is providing innovative evidence-based solutions for ... has commenced an underwritten public offering of its common ... Nevro and 2,459,175 shares to be sold by certain ... the underwriters a 30-day option to purchase up to ...
(Date:6/1/2015)... MENLO PARK, Calif. , June 1, ... (OTCQX: DMPI) ("DelMar" and the "Company"), a biopharmaceutical ... therapies in new orphan drug indications, today announced ... trial of  VAL-083  (dianhydrogalactitol) in patients with refractory ... form of human brain cancer. Results ...
(Date:6/1/2015)... CEFALY Technology , the creators of ... authorized for use prior to the onset of migraine ... trial showing that the Cefaly device returns normal metabolic ... patients, namely the orbitofrontal cortex and rostral cingulate. ... an imaging test of the brain, used a radioactive substance called a ...
Breaking Medicine Technology:Nevro Announces Proposed Public Offering of Common Stock 2Nevro Announces Proposed Public Offering of Common Stock 3DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 2DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 3DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 4DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 5DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 6DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 7DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 8New Study Shows CEFALY Returns Normal Metabolic Activity to Brain Areas in Migraine Patients 2
... Lobob hard contact lens cleaning ... to use, and professionally proven ... non-ionic detergents resulting in a ... protein deposits, cosmetic residue, salts, ...
Optimum C/D/S Solution is a sterile cleaning, disinfecting, and storage solution for use with fluorosilicone acrylate and silicone acrylate rigid gas permeable (RGP) and hard contact lenses....
Round knurled handle. Overall length 130 mm....
5 inch (12.7 cm), 2 x 5 mm blade....
Medicine Products: